FOSTER AEROSOL 100MG 6MG/DOSE

Packaging

Bottle of 120 doses.

Mechanism of action

Foster has an anti-inflammatory effect, reduces the severity of symptoms of bronchial asthma and reduces the frequency of exacerbations of the disease, while having a lower incidence of side effects than systemic GCS.

Indications and usage

Basic therapy of bronchial asthma, providing for the appointment of a combination therapy (inhaled glucocorticosteroid and β 2 long-acting adrenergic mimic):
Patients whose symptoms of the disease are not well controlled by inhaled glucocorticosteroids and β 2 short-acting adrenergic mimetics.
Patients receiving effective maintenance doses of inhaled glucocorticosteroids and long-acting β 2 adrenergic mimetics.

Contraindications

Hypersensitivity to Foster components, children under 12 years old.
Carefully:
Pregnancy, lactation period, pulmonary tuberculosis, fungal, viral or bacterial respiratory infections, thyrotoxicosis, pheochromocytoma, diabetes mellitus, uncontrolled hypokalemia, idiopathic hypertrophic subaortic stenosis, atrioventricular block III,severe arterial hypertension, aneurysm of any location or other severe cardiovascular diseases (acute myocardial infarction, coronary heart disease, tachyarrhythmia, decompensated chronic heart failure, prolonged Q-Tc interval (taking formoterol may cause prolongation of the QTc interval)).

Dosage and administration

Selection of the dose of drugs that are part of Foster, occurs individually and depending on the severity of the disease. For adults and adolescents over 12 years old: 1-2 inhalations twice a day. Patients should be under the constant supervision of a physician for adequate selection of the dose of Foster. The dose should be reduced to the lowest, against which the optimal control of the symptoms of bronchial asthma is maintained. When achieving complete control over the symptoms of bronchial asthma on the background of the minimum recommended dose of the drug, in the next step, you can try the appointment of monotherapy with inhaled glucocorticosteroids.
There is no need for a special selection of the dose of the drug for elderly patients.

Adverse reactions

Among the most frequent side effects associated with taking formoterol, described are typical for beta2-adrenergic mimics, such as: hypokalemia, headache, tremor, palpitations, cough, muscle cramps, prolongation of the QTc interval. Side effects characteristic of beclomethasone dipropionate: candidiasis of the mucous membrane of the mouth and throats, irritation in the throat.
Like other inhalants, Foster can cause paradoxical bronchospasm.
Other side effects typical of formoterol are: thrombocytopenia, angioedema, hyperglycemia, increased insulin levels in the blood, free fatty acids, glycerol and ketone derivatives, sleep disorders, hallucinations, fatigue, anxiety, changes in taste (dysgeusia), tachycardia, laxity, anxiety, changes in taste (dysgeusia), tachycardia, laxity, anxiety, changes in taste, disability, tachycardia, and tachycardia. ventricular premature beats, angina (ischemic heart disease), atrial fibrillation, arterial hypertension, arterial hypotension, exacerbation of bronchial asthma, shortness of breath, nausea, itching, Common rash, urticaria, hyperhidrosis, myalgia, nephritis, peripheral edema.

Special notes

It is recommended to instruct the patient about the need to rinse the mouth with water after inhalation of maintenance doses in order to prevent the risk of developing candidiasis of the mucous membrane of the oral cavity and pharynx.

The balloon is under pressure: do not expose to heat, do not pierce, do not throw into the fire, even empty. Use within 3 months from the start of use.

Drug Interactions

Β-adrenergic receptor blockers may weaken the action of formoterol. Foster should not be administered simultaneously with b-adrenoblockers (including eye drops), except in forced cases.

In the dark place at a temperature of no higher than 25 ° C.